SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New Standard of Care in High-Risk Acute Promyelocytic Leukemia?

2.

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

3.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

4.

Small Renal Mass Surveillance Does Not Affect Nephron-Sparing Surgery.

5.

Vaccine elicits strong immune response in patients with pancreatic and colorectal cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot